Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).
作者信息
Janssen H L, Brouwer J T, Nevens F, Sanchez-Tapias J M, Craxi A, Hadziyannis S
机构信息
Department of Internal Medicine II, University Hospital Dijkzig, Rotterdam, The Netherlands.
出版信息
BMJ. 1993 Jan 9;306(6870):107-8. doi: 10.1136/bmj.306.6870.107.
Abstract
摘要
相似文献
1
Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep).与α干扰素相关的致命性肝失代偿。欧洲病毒性肝炎协作行动（欧洲肝炎协作组）
BMJ. 1993 Jan 9;306(6870):107-8. doi: 10.1136/bmj.306.6870.107.
2
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].[病毒性肝硬化：自然病程、发病机制及并发症的临床意义]
Ann Ital Med Int. 1996 Oct;11 Suppl 2:23S-29S.
3
Portal systemic encephalopathy (PSE).门体性脑病
J Pak Med Assoc. 1987 Feb;37(2):25-33.
4
[Cirrhosis and its complications].[肝硬化及其并发症]
Rev Prat. 2005 May 31;55(10):1135-41.
5
Hepatic decompensation in patients with cirrhosis during infection with influenza A.甲型流感感染期间肝硬化患者的肝失代偿
Arch Intern Med. 2000 Jan 10;160(1):113-5. doi: 10.1001/archinte.160.1.113.
6
Liver cirrhosis. Clinical experience with 274 unselected cases.肝硬化。274例未经挑选病例的临床经验。
Digestion. 1971;4(4):223-33. doi: 10.1159/000197123.
7
Hepatitis: update on diagnosis and management.肝炎：诊断与管理的最新进展。
Prim Care. 1979 Mar;6(1):81-95.
8
Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement.应用肝脏硬度测量评估组织学证实的乙型肝炎肝硬化发生肝失代偿的风险。
Digestion. 2012;85(3):219-27. doi: 10.1159/000335430. Epub 2012 Mar 8.
9
10
[Features of onset of chronic severe hepatitis in 520 cases].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Dec;16(4):322-5.
引用本文的文献
1
Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg).乙肝病毒感染患者中的肝细胞癌及乙肝表面抗原（HBsAg）的作用
J Clin Med. 2022 Feb 21;11(4):1126. doi: 10.3390/jcm11041126.
2
HBV/HDV Coinfection: A Challenge for Therapeutics.HBV/HDV 合并感染：治疗的挑战。
Clin Liver Dis. 2019 Aug;23(3):557-572. doi: 10.1016/j.cld.2019.04.005. Epub 2019 May 24.
3
The Role of Interferon in Hepatitis B Therapy.干扰素在乙型肝炎治疗中的作用。
Curr Hepat Rep. 2010 Nov;9(4):231-238. doi: 10.1007/s11901-010-0055-1. Epub 2010 Aug 26.
4
Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report.拉米夫定耐药乙型肝炎病毒再激活导致的致命性肝衰竭：一例报告
World J Gastroenterol. 2007 Feb 14;13(6):964-9. doi: 10.3748/wjg.v13.i6.964.
5
Diabetes mellitus during interferon therapy for chronic viral hepatitis.慢性病毒性肝炎干扰素治疗期间的糖尿病
Dig Dis Sci. 2002 Jul;47(7):1649-54. doi: 10.1023/a:1015852110353.
6
The effect of low-dose interferon treatment on visual evoked potentials.低剂量干扰素治疗对视诱发电位的影响。
Doc Ophthalmol. 1997;94(3):215-21. doi: 10.1007/BF02582980.
7
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.低剂量α干扰素疗法对慢性活动性丙型肝炎可能有效。一项多中心随机试验的结果。
Gut. 1996 Apr;38(4):603-9. doi: 10.1136/gut.38.4.603.
8
Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.干扰素α-2a。其药理学特性及在病毒性肝炎治疗中的应用综述。
Drugs. 1995 Nov;50(5):873-96. doi: 10.2165/00003495-199550050-00007.
9
Clinical toxicity of the interferons.
Drug Saf. 1994 Feb;10(2):115-50. doi: 10.2165/00002018-199410020-00003.
本文引用的文献
1
Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis.慢性乙型肝炎中与乙肝e抗原清除相关的肝脏失代偿
Gastroenterology. 1985 Oct;89(4):732-5. doi: 10.1016/0016-5085(85)90566-9.
2
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.重组干扰素α治疗慢性丙型肝炎。一项多中心随机对照试验。
N Engl J Med. 1989 Nov 30;321(22):1501-6. doi: 10.1056/NEJM198911303212203.
3
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.一项关于单独使用干扰素α-2b以及停用泼尼松后治疗慢性乙型肝炎的随机对照试验。肝炎介入治疗组。
N Engl J Med. 1990 Aug 2;323(5):295-301. doi: 10.1056/NEJM199008023230503.
4
Liver failure due to recombinant alpha interferon.
Lancet. 1991 Nov 16;338(8777):1268-9. doi: 10.1016/0140-6736(91)92132-l.
Zotero 插件